After patient follow-up, we found that high levels of CD73 in tumor cells were associated with a significantly decreased overall survival (16.4 months ± 1.349 months vs. 25.400 months ± 7.965 months; p = 0.007) (Fig. 1e). Here, NT5E is linked to neoplasm.